Biognosys AG

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and Antibody drug Conjugates (ADCs). Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

Our platform enables efficient, tunable multiplex gene silencing, modulating multiple targets in one construct for superior safety and potency over traditional editing. Its modular design suits various cell and gene engineering applications.

Accelerate your development with CMC & More  *   In today's fast pace environment, optimizing your CMC (Chemistry, Manufacturing & Controls) package is crucial for cost-effective and timely product development. CMC & More is specialized in providing tailored advisory services that cater your ne